THE DEAL, AT A GLANCE
From the announcementAqua Medical
01What it doesThe Aqua Medical Radiofrequency Vapor Ablation System is FDA-cleared for ablation in the gastrointestinal tract, including Barrett's esophagus.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Relevance VenturesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAqua Medical raised $589M Series B, announced 2026-09-25From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersAqua Medical's Series B thesis is that financing can move its investigational PIMA procedure for Type 2 diabetes from an actively enrolling U.S.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Aqua Medical · Financing Record
Explore source-linked visual explanations for Aqua Medical. Unsupported claims are withheld while source review continues.
Record 12760 · Recorded date: 2026-09-25
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →